Acadia Pharmaceuticals Inc.

About Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc. is a pharmaceutical company specializing in breakthroughs in neuroscience to enhance lives. For over 30 years, Acadia has been at the forefront of healthcare, pioneering treatments for conditions like Parkinson’s disease psychosis and Rett syndrome. The company's focus is on developing innovative and novel medicines that address unmet medical needs, especially in therapeutic areas with high demand, such as Prader-Willi syndrome, Alzheimer’s disease psychosis, and other central nervous system disorders. Acadia is dedicated to elevating life by embracing diverse perspectives, fostering collaboration, and advancing scientific research and development.